Jane Street Group, LLC Aerie Pharmaceuticals Inc Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 16, 2021	BUY	$11.32 - $16.63 $107,540 - $157,985	9,500 Added 190.0%	14,500 $165,000
Q2 2018 Aug 15, 2018	BUY	$47.85 - $70.45 $239,250 - $352,250	5,000 New	5,000 $338,000
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $838,860 - $1 Million	-16,400 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$50.85 - $65.1 $167,805 - $214,829	3,300 Added 25.19%	16,400 $980,000
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $636,660 - $787,310	13,100	13,100 $637,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.